global-alert
global messaging alerts

Fierce Pharma: “Next Supply Chain Challenge: Syringes”

template-parts/default.php

Fierce Pharma: “Next Supply Chain Challenge: Syringes”

An estimated 14 to 19 billion incremental injections will be required by year-end 2022 to vaccinate the world’s population against COVID-19 while supplying related boosters and adjuvants. In response, the industry is shifting billions of syringes from routine vaccinations and therapeutics to COVID, increasing existing capacity, and building new manufacturing sites for syringes. Yet COVID’s supply chain is still expected to fall short. What is the source of this looming shortage? Is “syringe nationalism” causing export embargoes? How is the industry responding? Is it a supply chain problem?

In this webinar, three experts in pharma and global health discuss potential solutions including,

  • Onshoring of production
  • Increasing capacity in existing plants
  • Investing in new facilities
  • Need for Government funding of long-term supply chain infrastructure
  • Resources and technical know-how required for production
  • Need for trained local personnel to put “shots in arms”

Presenters

  • Ed Kelley, PhD, Chief Global Health Officer, ApiJect
  • Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals

INTERPHEX Live 2021: “Creating a Sustainable Public Health Supply Chain”

template-parts/default.php

INTERPHEX Live 2021: “Creating a Sustainable Public Health Supply Chain”

Industry experts share insights on how stakeholders can maintain a robust, resilient supply chain essential to global health and vaccine security, with an accelerated response time to meet the needs of current and future pandemics. The building blocks for this supply chain resiliency include tech transfer, designing for right-size capacity, improving operational efficiencies, implementing state-of-the-art technologies, and establishing regulatory and quality systems.


Presenters

  •  Ed Kelley, PhD, former Director of Integrated Health Services for WHO and Chief Global Health Officer for ApiJect
  • Rob Roy, PE, Director of Aseptic Technology at IPS-Integrated Project Services
  • Paul Fisher, Director of Process Architecture at IPS-Integrated Project Services
  • Jim Fries, Chief Executive Officer, RX-360

INTERPHEX Live 2021 Session: “Pros and Cons of Global Fill-Finish”

template-parts/default.php

INTERPHEX Live 2021 Session: “Pros and Cons of Global Fill-Finish”

Responding to the COVID-19 pandemic, governments and public health agencies worldwide are developing quality vaccine programs, including local fill-finish capacity, to support global immunization. Yet even before COVID, countries were already facing increased vaccine demand due to population growth. The panel will discuss key challenges and opportunities as governments and pharmaceutical manufacturers seek to establish fill-finish facilities around the world to enable access to greater and more diversified vaccine manufacturing while improving preparedness to respond to future pandemics.

Presenters

  • Ed Kelley, PhD, former Director of Integrated Health Services for WHO; Chief Global Health Officer,  ApiJect
  • Jason Collins, AIA, Director of Process Architecture, IPS-Integrated Project Services
  • Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals
random footer image
Follow by Email
Twitter
YouTube
YouTube
LinkedIn
LinkedIn